ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p465.xmlWhy, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p465.pdf2026-04-18Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p462.xmlPathways: A Road to Restriction?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p462.pdf2026-04-18Pathways: A Road to Restriction?https://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p459.xmlTexting the Doctor2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p459.pdf2026-04-18Texting the Doctorhttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-pxlv.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-pxlv.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-pxxxvii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-pxxxvii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-pxxx.xmlErratum2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-pxxx.pdf2026-04-18Erratumhttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p484.xmlNon-Hodgkin's Lymphomas2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p484.pdf2026-04-18Non-Hodgkin's Lymphomashttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p575.xmlRole of Routine Imaging in Lymphoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p575.pdf2026-04-18Role of Routine Imaging in Lymphomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p563.xmlOptimization of Postremission Therapy in Follicular Lymphoma: Efficacy of Rituximab Maintenance2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/9/5/article-p563.pdf2026-04-18Optimization of Postremission Therapy in Follicular Lymphoma: Efficacy of Rituximab Maintenance